Literature DB >> 24531723

Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment?: Science & Society series on "Drugs and Science".

David Nutt1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24531723      PMCID: PMC3989684          DOI: 10.1002/embr.201338282

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  11 in total

1.  Drug harms in the UK: a multicriteria decision analysis.

Authors:  David J Nutt; Leslie A King; Lawrence D Phillips
Journal:  Lancet       Date:  2010-10-29       Impact factor: 79.321

2.  Response of cluster headache to psilocybin and LSD.

Authors:  R Andrew Sewell; John H Halpern; Harrison G Pope
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

3.  Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.

Authors:  Francisco A Moreno; Christopher B Wiegand; E Keolani Taitano; Pedro L Delgado
Journal:  J Clin Psychiatry       Date:  2006-11       Impact factor: 4.384

4.  Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Authors:  Robin L Carhart-Harris; David Erritzoe; Tim Williams; James M Stone; Laurence J Reed; Alessandro Colasanti; Robin J Tyacke; Robert Leech; Andrea L Malizia; Kevin Murphy; Peter Hobden; John Evans; Amanda Feilding; Richard G Wise; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

5.  New victims of current drug laws.

Authors:  David J Nutt; Leslie A King; David E Nichols
Journal:  Nat Rev Neurosci       Date:  2013-10-23       Impact factor: 34.870

6.  Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.

Authors:  R L Carhart-Harris; R Leech; T M Williams; D Erritzoe; N Abbasi; T Bargiotas; P Hobden; D J Sharp; J Evans; A Feilding; R G Wise; D J Nutt
Journal:  Br J Psychiatry       Date:  2012-01-26       Impact factor: 9.319

7.  The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.

Authors:  R L Carhart-Harris; M B Wall; D Erritzoe; M Kaelen; B Ferguson; I De Meer; M Tanner; M Bloomfield; T M Williams; M Bolstridge; L Stewart; C J Morgan; R D Newbould; A Feilding; H V Curran; D J Nutt
Journal:  Int J Neuropsychopharmacol       Date:  2013-12-17       Impact factor: 5.176

8.  Broadband cortical desynchronization underlies the human psychedelic state.

Authors:  Suresh D Muthukumaraswamy; Robin L Carhart-Harris; Rosalyn J Moran; Matthew J Brookes; Tim M Williams; David Errtizoe; Ben Sessa; Andreas Papadopoulos; Mark Bolstridge; Krish D Singh; Amanda Feilding; Karl J Friston; David J Nutt
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

9.  Effects of Schedule I drug laws on neuroscience research and treatment innovation.

Authors:  David J Nutt; Leslie A King; David E Nichols
Journal:  Nat Rev Neurosci       Date:  2013-06-12       Impact factor: 34.870

10.  Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Authors:  Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Scott F Martin; Berra Yazar-Klosinski; Yvonne Michel; Timothy D Brewerton; Rick Doblin
Journal:  J Psychopharmacol       Date:  2012-11-20       Impact factor: 4.153

View more
  3 in total

Review 1.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 2.  New Paradigms of Old Psychedelics in Schizophrenia.

Authors:  Danish Mahmood; Sattam K Alenezi; Md Jamir Anwar; Faizul Azam; Kamal A Qureshi; Mariusz Jaremko
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

3.  Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.

Authors:  Jakob A Shimshoni; Ilan Winkler; Ezekiel Golan; David Nutt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-20       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.